Hematopoietic Stem Cell Transplantation and Immune System Suppression in Severe Aplastic Anemia
نویسندگان
1 PhD Candidate in Nursing, Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran - PhD Candidate in Nursing, Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran
2 BSc of Nursing, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran - BSc of Nursing, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran
3 Associate Professor, Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran - Associate Professor, Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran
4 Professor, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran - Professor, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran
5 BSc of Nursing, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran - BSc of Nursing, Clinical Research Development Unit of Amirkola Children's Hospital, Babol University of Medical Sciences, Babol, IR Iran
doi
10.18502/ijpho.v15i3.18923چکیده
Aplastic anemia (AA) is characterized by pancytopenia and hypocellular bone marrow and can be either acquired or constitutional. Acquired AA results from autoimmune-mediated destruction of hematopoietic stem cells, often triggered by toxic agents inducing neo or cryptic antigens that activate immune responses. Although rare, acquired AA remains a serious condition typically ...
